Hinge Health (HNGE) Insider Group Sells 533,228 Shares

Insight Holdings Group Sells 533,228 Shares of Hinge Health

LLC Insight Holdings Group executed a notable transaction on June 24, 2026, selling 533,228 shares of Hinge Health, Inc. (NYSE: HNGE). This move is part of a broader string of back-and-forth trading activity by the group through late June, which has included both acquisitions and planned sales of company shares.

Recent Insider Transactions at Hinge Health

The group has been highly active in its dealings with Hinge Health stock. On June 22, 2026, Insight Holdings sold 224,399 shares in a planned transaction at an average price of $70.96, totaling about $15.92 million. The very next day, on June 23, 2026, the group bought 112,477 shares, but also executed a planned sale of 112,477 shares at $70.21 apiece for roughly $7.89 million. On June 25, 2026, the group picked up another 530,982 shares. Activity peaked on June 29, 2026, when the entity acquired 1,466,667 shares while simultaneously parting with 1,466,667 shares in a planned sale priced at $82.84 per share, worth a substantial $121.49 million.

Hinge Health Stock Performance and Valuation

Hinge Health shares trade at $70.56, placing the company with a market capitalization of $8.47 billion. The stock's valuation includes a P/E ratio of 34.64 and a forward P/E of 34.33. Over the past year, the equity has traded as low as $30.08 and as high as $107.00. It currently rests above its 200-day moving average of $63.28, though below its 50-day moving average of $92.61.

Analysts Set New Price Targets

Analyst backing remains strong for Hinge Health, anchored by a consensus buy rating across 16 covering firms. Keybanc maintains an Overweight rating with a $140.00 price target as of October 16, 2026, up from $125.00. Barclays also holds an Overweight rating with a $110.00 target set on October 12, 2026. Needham reiterated a Buy rating on September 30, 2026, lifting its target to $115.00 from $97.00, while Baird keeps a Neutral stance with a $90.00 target as of September 22, 2026.

Inside Hinge Health Operations

Headquartered in San Francisco, California, Hinge Health builds technology-driven care platforms focused on musculoskeletal system care, covering everything from acute injuries to post-surgical rehabilitation. The company utilizes AI-powered motion tracking and wearable nerve stimulation devices, primarily serving self-insured employers through its digital health framework.

What to Watch Next for HNGE

Investors will look toward Hinge Health's upcoming earnings report scheduled for November 2, 2026, to gauge the company's financial momentum following a revenue of $720.06 million and solid net margins. Insider filings will continue to track whether Insight Holdings adjusts its sizable position further.